Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).

Sung Hoon SimIn Hae ParkKyung Hae JungSung-Bae KimJin-Hee AhnKyung-Hun LeeSeock-Ah ImYoung-Hyuck ImYeon Hee ParkJoohyuk SohnYu Jung KimSuee LeeHee-Jun KimYee Soo ChaeKyong Hwa ParkByung-Ho NamKeun Seok LeeJungsil Ro

Published in: British journal of cancer (2019)

ClinicalTrials.gov number NCT01730677.

Keyphrases

metastatic breast cancer
open label
phase ii study
clinical trial
double blind
placebo controlled
study protocol
randomized controlled trial
rectal cancer